{"id":"gadoxetic-acid-enhanced-liver-mri","safety":{"commonSideEffects":[{"rate":null,"effect":"Gadolinium deposition in tissues"},{"rate":"<0.1","effect":"Nephrogenic systemic fibrosis (rare, in severe renal impairment)"},{"rate":"1-5","effect":"Injection site reactions"},{"rate":"1-3","effect":"Headache"},{"rate":"1-2","effect":"Nausea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Gadoxetic acid is a hepatobiliary contrast agent containing gadolinium that is taken up by hepatocytes via organic anion transporters and excreted into bile. This dual uptake mechanism allows for both vascular phase imaging (from the gadolinium contrast effect) and hepatobiliary phase imaging (from hepatocyte accumulation), improving detection and characterization of focal liver lesions on MRI.","oneSentence":"Gadoxetic acid is a gadolinium-based contrast agent that accumulates in hepatocytes to enhance MRI visualization of liver tissue and detect lesions.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:47:00.741Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Liver MRI for detection and characterization of focal hepatic lesions"},{"name":"Evaluation of cirrhosis and hepatocellular carcinoma"}]},"trialDetails":[{"nctId":"NCT06130280","phase":"PHASE2","title":"A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2023-11-08","conditions":"Colorectal Cancer, Liver Metastases","enrollment":32},{"nctId":"NCT07223307","phase":"PHASE2","title":"REGULUS: MRI-guided Adaptive SABR for Liver Cancers","status":"RECRUITING","sponsor":"Stanford University","startDate":"2026-01-23","conditions":"Liver Cancer, Intrahepatic Cholangiocarcinoma, Liver Metastases","enrollment":62},{"nctId":"NCT02156739","phase":"NA","title":"Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2014-10-13","conditions":"Hepatocellular Carcinoma, Liver and Intrahepatic Bile Duct Disorder, Metastatic Malignant Neoplasm in the Liver","enrollment":100},{"nctId":"NCT05314400","phase":"NA","title":"Gadoxetate Abbreviated MRI in Metastatic Colorectal Cancer","status":"RECRUITING","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2022-07-01","conditions":"Liver Metastasis Colon Cancer","enrollment":200},{"nctId":"NCT06905054","phase":"PHASE2","title":"Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-04-15","conditions":"Primary Sclerosing Cholangitis, Liver Transplant, Complications, PSC","enrollment":80},{"nctId":"NCT07010588","phase":"NA","title":"Comparison of ultraSound, Abbreviated MRI witH and Without HBP aS mOdalities for HCC suRveillance in patienTs With High Risk","status":"NOT_YET_RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2025-06","conditions":"Hepatocellular Carcinoma (HCC), Magnetic Resonance Imaging (MRI), Randomized Controlled Trial","enrollment":1389},{"nctId":"NCT06106568","phase":"","title":"An Observational Study to Learn More About the Impact of Gadoxetate Sodium-Enhanced Magnetic Resonance Imaging (EOB-MRI) When Used to Diagnose the Spread of Cancer From the Pancreas to the Liver in Japanese People Under Real-World Conditions","status":"COMPLETED","sponsor":"Bayer","startDate":"2023-11-20","conditions":"Metastatic Pancreatic Cancer, Liver Metastases, Gadoxetate Sodium-enhanced Magnetic Resonance Imaging","enrollment":39624},{"nctId":"NCT06437457","phase":"","title":"Comparison of Gd-EOB-DTPA-enhanced MRI and Contrast-enhanced Ultrasound for Measuring Tumor Size of Solitary Hepatocellular Carcinoma ≤ 5cm:A Retrospective Study","status":"COMPLETED","sponsor":"Anhui Medical University","startDate":"2019-01-01","conditions":"HCC - Hepatocellular Carcinoma","enrollment":194},{"nctId":"NCT01082224","phase":"NA","title":"Contrast-Enhanced CT and MRI in Diagnosing and Staging Liver Cancer Using UNOS Policy","status":"UNKNOWN","sponsor":"American College of Radiology Imaging Network","startDate":"2010-12","conditions":"Liver Cancer","enrollment":440},{"nctId":"NCT05182099","phase":"NA","title":"High Resolution HBA-MRI Using Deep Learning Reconstruction","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2022-01-10","conditions":"Liver Diseases, Magnetic Resonance Imaging, Deep Learning","enrollment":52},{"nctId":"NCT05592106","phase":"","title":"Gd-EOB-DTPA-enhanced T1 Map for Predicting Postoperative Liver Failure","status":"COMPLETED","sponsor":"Shanghai Zhongshan Hospital","startDate":"2021-10-10","conditions":"Liver Failure","enrollment":40},{"nctId":"NCT05296434","phase":"","title":"Delta Radiomics for Liver Function Evaluation","status":"UNKNOWN","sponsor":"Zhujiang Hospital","startDate":"2022-04-01","conditions":"Chronic Liver Disease","enrollment":60},{"nctId":"NCT02395991","phase":"","title":"Evaluation of Transient Dyspnea During Gadoxetic Acid Enhanced Multiphasic Liver MRI","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2015-04","conditions":"Dyspnea","enrollment":60},{"nctId":"NCT03342677","phase":"NA","title":"Evaluation of Gd-EOB-DTPA MRI for Detection and Characterization of Liver Nodules in Cirrhotic Patients Undergoing Liver Transplantation and Potential Impact on Transplant Eligibility","status":"UNKNOWN","sponsor":"University Health Network, Toronto","startDate":"2017-11-07","conditions":"Hepatocellular Carcinoma","enrollment":80},{"nctId":"NCT04559451","phase":"","title":"Assessment of Remnant Liver Function in ALPPS by Gd-EOB-DTPA Enhanced MRI","status":"UNKNOWN","sponsor":"Peking University Third Hospital","startDate":"2020-10-01","conditions":"Liver Function Failure, Liver Malignant Tumors","enrollment":60},{"nctId":"NCT03742453","phase":"NA","title":"Evaluation of Diagnostic Accuracy of CEUS for HCC Diagnosis","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2018-10-16","conditions":"Hepatocellular Carcinoma","enrollment":117},{"nctId":"NCT03215355","phase":"PHASE4","title":"Improving CBCT for Liver IG-SBRT Using Gadoxetate Disodium","status":"WITHDRAWN","sponsor":"Slawa Cwajna","startDate":"2017-08","conditions":"Primary Liver Cancer, Metastatic Liver Cancer","enrollment":""},{"nctId":"NCT01126645","phase":"PHASE2","title":"Sorafenib and Micro-therapy Guided by Primovist Enhanced MRI in Patients With Inoperable Liver Cancer","status":"COMPLETED","sponsor":"University of Magdeburg","startDate":"2010-12","conditions":"Hepatocellular Carcinoma","enrollment":529},{"nctId":"NCT01446666","phase":"","title":"Gadoxetic Acid-MRI Versus Ultrasonography for the Surveillance of Hepatocellular Carcinoma in High-risk Patients","status":"COMPLETED","sponsor":"Asan Medical Center","startDate":"2011-11","conditions":"Cirrhosis of Liver","enrollment":423},{"nctId":"NCT02854371","phase":"PHASE4","title":"Evaluation of Hepatic Function Using Gadoxetic Acid Enhanced MRI","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2016-08","conditions":"Cirrhosis","enrollment":54},{"nctId":"NCT01490203","phase":"","title":"Evaluation of Remnant Liver Function Using Primovist-enhanced MRI Before Resection/Ablation of Hepatocellular Carcinoma","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2011-12","conditions":"Carcinoma, Hepatocellular, Liver Dysfunction","enrollment":71},{"nctId":"NCT03045419","phase":"","title":"Added Value of Gadoxetic Acid-enhanced Liver MRI","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2009-12-29","conditions":"Hcc, Diagnosis","enrollment":130},{"nctId":"NCT01043523","phase":"","title":"Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.","status":"COMPLETED","sponsor":"Bayer","startDate":"2009-12","conditions":"Liver Neoplasms, Adenoma, Carcinoma","enrollment":52},{"nctId":"NCT02084628","phase":"PHASE3","title":"Magnetic Resonance Imaging of the Liver in Children 0-2 Months of Age With an Intravenous Injection of Eovist/Primovist Which is a Contrast Agent","status":"TERMINATED","sponsor":"Bayer","startDate":"2015-02","conditions":"Magnetic Resonance Imaging","enrollment":1},{"nctId":"NCT02652663","phase":"","title":"Liver MRI for Colorectal Cancer Liver Metastasis: Comparative Effectiveness Research for the Choice of Contrast Agents","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2016-01","conditions":"Colorectal Cancer","enrollment":500},{"nctId":"NCT02578602","phase":"PHASE1","title":"MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer","status":"COMPLETED","sponsor":"University of Southern California","startDate":"2010-10","conditions":"Adult Hepatocellular Carcinoma, Advanced Adult Hepatocellular Carcinoma, BCLC Stage 0 Adult Hepatocellular Carcinoma","enrollment":26},{"nctId":"NCT00526188","phase":"PHASE3","title":"Efficacy and Safety of Primovist in Chinese Patients","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-08","conditions":"Known or Suspected Focal Liver Lesions","enrollment":234},{"nctId":"NCT01522209","phase":"NA","title":"Detection Rate of Liver Metastases With Contrast Enhanced Intraoperative Ultrasound Compared to Regular Imaging","status":"COMPLETED","sponsor":"Asklepios Kliniken Hamburg GmbH","startDate":"2011-12","conditions":"Colon Cancer Liver Metastasis, Contrast Enhances Intraoperative Ultrasound, Imaging for Liver Cancer","enrollment":59},{"nctId":"NCT01255007","phase":"NA","title":"Comparison of Primovist-enhanced MRI, Diffusion Weighted MRI and Multidetector CT of Colorectal Liver Metastases","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2010-09","conditions":"Colorectal Liver Metastases","enrollment":50},{"nctId":"NCT00764621","phase":"PHASE4","title":"Health Economic Evaluation of Primovist-enhanced Liver MRI","status":"COMPLETED","sponsor":"Bayer","startDate":"2008-10","conditions":"Colorectal Neoplasms, Neoplasm Metastasis","enrollment":360},{"nctId":"NCT01501240","phase":"","title":"Gadoxetic Acid-enhanced MR Evaluation of Hepatocellular Carcinoma and Dysplastic Nodules in the Cirrhotic Liver","status":"WITHDRAWN","sponsor":"Jae Ho Byun","startDate":"2012-01","conditions":"Liver Cirrhosis, Carcinoma, Hepatocellular","enrollment":""},{"nctId":"NCT01764438","phase":"","title":"Utility Study of Primovist-MRI on HCC Staging","status":"UNKNOWN","sponsor":"Inha University Hospital","startDate":"2012-08","conditions":"Hepatocellular Carcinoma","enrollment":174},{"nctId":"NCT01341132","phase":"","title":"Evaluation of Cirrhosis and Malignant Hepatic Lesions Using Novel MR Contrast Agents","status":"UNKNOWN","sponsor":"San Francisco Veterans Affairs Medical Center","startDate":"2011-05","conditions":"Hepatocellular Carcinoma","enrollment":75}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":73,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Primovist","Eovist"],"phase":"marketed","status":"active","brandName":"gadoxetic acid enhanced liver MRI","genericName":"gadoxetic acid enhanced liver MRI","companyName":"Seoul National University Hospital","companyId":"seoul-national-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Gadoxetic acid is a gadolinium-based contrast agent that accumulates in hepatocytes to enhance MRI visualization of liver tissue and detect lesions. Used for Liver MRI for detection and characterization of focal hepatic lesions, Evaluation of cirrhosis and hepatocellular carcinoma.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}